HOME >> BIOLOGY >> NEWS
ESC Congress 2005 to utilise studies, sessions and sunshine to shed light on women and CVD

Sophia Antipolis, France, 21 June 2005: With the aim of better understanding and addressing women and cardiovascular disease (CVD), the European Society of Cardiology (ESC) has made women and CVD the focus of its next major annual event, the ESC Congress, which will take place in Stockholm, 3 7 September 2005.

The ESC Congress will highlight women and CVD by revealing results from the ESC Policy Conference and the ESC Euro Heart Survey during specific sessions at the Congress. The ESC also will provide information with regard to women and CVD during a two-day outdoor public event that will run alongside the ESC Congress, entitled 'For Your Heart's Sake,' 2 3 September 2005 in central Stockholm.

In preparation for the ESC Congress' focus, the ESC is convening a Policy Conference on 'CVD in Women' on 23 24 June 2005, which will bring together approximately 60 cardiologists and experts from the 49 ESC member countries to review and discuss medical literature on CVD in women. The group will evaluate the gap between scientific data and the perception about the role of CVD risk factors in women's health. Strategies will be discussed to promote research in the field of CVD in women and to educate both cardiologists and their patients. The results of this conference will be released during the ESC Congress 2005, and also through an article to be published in the European Heart Journal, an official journal of the ESC.

The ESC Congress' selection of sessions on women and CVD will include release of the Euro Heart Survey database analyses with incidence and treatment trends of women with CVD across Europe. Analyses of the Euro Heart Survey databases are expected to greatly contribute to an increased understanding and treatment of women and CVD through insight into manifestation, treatment and co-morbidity patterns in women compared to men.

There will also be a special focus on women and CVD, including specific information on risk factor reduc
'"/>

Contact: Gina Dellios
gdellios@escardio.org
33-492-948-627
European Society of Cardiology
21-Jun-2005


Page: 1 2 3

Related biology news :

1. AAAS analysis finds Congress would add billions to FY 2008 R&D investment
2. 2nd International EuroFIR Congress
3. Prize winners announced at ISNs World Congress of Nephrology
4. Nanotechnologys past, present and future: A Congressional perspective
5. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
6. Minister Lunn to speak at 10th National Forest Congress
7. Conservationist and actor Harrison Ford honored by Congressional Foundation
8. Q&A with Jeffrey Sachs on July 10 at Soils Congress
9. 18th World Congress of Soil Science
10. PITTs McGowan Institute for Regenerative Medicine presenting new research at World Congress
11. International Society of Nephrologys World Congress of Nephrology 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/3/2017)... WASHINGTON , Feb. 3, 2017 A ... Identity Strategy Partners, LLP (IdSP) . Designed to ... in the complex identity market, founding partners Mark ... nearly 35 combined years just in identity expertise that ... tank and non-profit leadership. The Crego-Kephart combined expertise has ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc , ... Compass Research . GGI's mission is to advance global health and highlight the ... need in honor of each clinical trial volunteer. The vision of GGI is to ...
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
Breaking Biology Technology:
Cached News: